,

The Vaccine Book

Specificaties
Paperback, blz. | Engels
Elsevier Science | 2016
ISBN13: 9780128021743
Rubricering
Elsevier Science e druk, 2016 9780128021743
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

The Vaccine Book, Second Edition provides comprehensive information on the current and future state of vaccines. It reveals the scientific opportunities and potential impact of vaccines, including economic and ethical challenges, problems encountered when producing vaccines, how clinical vaccine trials are designed, and how to introduce vaccines into widespread use.

Although vaccines are now available for many diseases, there are still challenges ahead for major diseases, such as AIDS, tuberculosis, and malaria. This book is designed for students, researchers, public health officials, and all others interested in increasing their understanding of vaccines. It answers common questions regarding the use of vaccines in the context of a rapidly expanding anti-vaccine environment.

This new edition is completely updated and revised with new and unique topics, including new vaccines, problems of declining immunization rates, trust in vaccines, the vaccine hesitancy, and the social value of vaccines for the community vs. the individual child’s risk.

Specificaties

ISBN13:9780128021743
Taal:Engels
Bindwijze:Paperback

Inhoudsopgave

<p>Part I: Understanding Vaccine Impact at Population and Individual Levels<br>1. The Impact of Vaccination on the Epidemiology of Infectious Diseases<br>2. How Vaccines Work</p> <p>Part II: How to Design, Assess and Produce Vaccines<br>3. Vaccine Design in the 21st Century<br>4. Vaccine Adjuvants<br>5. Vaccine Production: Main Steps and Considerations<br>6. How are Vaccines Assessed in Clinical Trials?<br>7. Immunological Correlates of Vaccine-Mediated Protection</p> <p>Part III: Vaccine Safety<br>8. How Vaccine Safety is Monitored<br>9. Vaccination and Autoimmune Diseases</p> <p>Part IV: New Vaccination Strategies<br>10. Maternal Immunization: Protecting Vulnerable Populations<br>11. New Challenges for Pertussis Vaccines</p> <p>Part V: Recently Introduced Vaccines<br>12. Pneumococcus, Pneumococcal Disease, and Prevention<br>13. Human Papillomavirus Vaccines<br>14. Rotavirus Vaccines</p> <p>Part VI: New Approaches for Needed Vaccines<br>15. Antiviral Vaccines: Challenges and Advances<br>16. New Approaches for Needed Vaccines: Bacteria<br>17. Vaccines Against Parasites</p> <p>Part VII: Major Global Vaccine Challenges<br>18. Tuberculosis Vaccines<br>19. Major Global Vaccine Challenges: Recent Progress in Malaria Vaccine Development<br>20. AIDS Vaccines<br>21. Influenza Vaccines and Vaccination Strategies</p> <p>Part VIII: Ethical Considerations<br>22. Ethical Considerations in Vaccine Trials in Resource-Limited Settings</p> <p>Part IX: Vaccine Economics<br>23. Economic Considerations for the Development of Global Vaccines: a Perspective From the Vaccine Industry<br>24. Introduction of Vaccines Into National Programs<br>25. Transitioning Immunization Into the Health Care System: Strengthening Routine Immunization in India</p> <p>Part X: Trust in Vaccines<br>26. Vaccine Acceptance<br>27. Trust and Confidence in Vaccines: Tales of Three Vaccines, Lessons for Others</p> <p>Part XI: Future Challenges<br>28. Vaccines for Emerging Viral Diseases<br>29. Cancer Immunotherapy by Checkpoint Blockade<br>30. Adoptive Cellular Therapy With Synthetic T Cells as an “Instant Vaccine” for Cancer and Immunity</p>

Rubrieken

    Personen

      Trefwoorden

        The Vaccine Book